Viamet Pharmaceuticals Inc — Form D/A
Viamet Pharmaceuticals Inc of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2011-02-18. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-02-18
- Form: D/A
- Accession: 0001336674-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $25.0M
- Amount sold: $25.0M
- Investors: 7
- Date of first sale: 2009-06-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-80342
Issuer
- Name: Viamet Pharmaceuticals Inc
- CIK: 0001336674
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2004
- Address: 2250 PERIMETER PARK DRIVE, MORRISVILLE, NC, 27560
- Phone: 919-467-8539
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Douglas Reed | Director | Durham, NC |
| James Rosen | Director | New York, NY |
| Robert Schotzinger | Director | Chapel Hill, NC |
| Lauren T Silverman | Director | Lexington, MA |
| S. Edward T Torres | Director | Indianapolis, IN |
| Andrew T von Eschenbach | Director | Montgomery, TX |
| William T White, III | Director | Chicago, IL |
| Neil T Moore | Executive Officer | Morrisville, NC |
| Robert Schotzinger | Executive Officer | Chapel Hill, NC |
| Garheng Kong | Director | Seattle, WA |
| LAUREN SILVERMAN | Director | CAMBRIDGE, MA |
| S. Edward Torres | Director | Indianapolis, IN |
| Neil Moore | Executive Officer | Morrisville, NC |
Other filings by this issuer (1)
More